<DOC>
	<DOC>NCT00137345</DOC>
	<brief_summary>The purpose of this study is to determine if one drug is superior to another with regard to safety and the preservation of renal function after a kidney transplant.</brief_summary>
	<brief_title>Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Dialysis patients who will be receiving their first kidney transplant Weight over 88 pounds (lbs.) Very high cholesterol levels Obesity Organ donor over 65 years of age if living; over 60 years of age if cadaveric.</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Randomized controlled trial</keyword>
	<keyword>Clinical Trial Phase III</keyword>
	<keyword>Drug therapy</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Treatment outcome</keyword>
	<keyword>Kidney transplantation</keyword>
	<keyword>Kidney function tests</keyword>
</DOC>